Ingevity News

Ingevity Is Maintained at Outperform by Oppenheimer

Ingevity Is Maintained at Outperform by Oppenheimer

Dow Jones37minutes ago

Ingevity Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 28.89% Oppenheimer $50 → $58 Maintains Outperform 04/22/2024 37.78% Jefferies $52 → $62 Upgrade

Benzinga47minutes ago

Analysts Offer Insights on Materials Companies: Ingevity (NGVT), Summit Materials (SUM) and Sandfire Resources Limited (OtherSFRRF)

TipRanks08:34 ET

Express News | Ingevity Corp. : Oppenheimer Raises Target Price to $58 From $50

Reuters08:04 ET

Ingevity (NGVT) Reports Q1 Earnings: What Key Metrics Have to Say

Yahoo Finance21:00 ET

Express News | Ingevity Reiterates FY24 Sales $1.40B-$1.55B Vs $1.462B Est

Benzinga18:00 ET

Ingevity: Q1 Earnings Snapshot

Barchart17:57 ET

Ingevity Corp (NGVT) Reports Q1 2024 Results: Challenges Persist Amid Strategic Repositioning

Yahoo Finance17:42 ET

Express News | Ingevity Corp - Reiterating Full Year Guidance of Sales and Adjusted Ebitda

Reuters16:54 ET

Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q1 Revenue $340.1M, Vs. Street Est of $319.2M

04:49 PM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (NGVT) INGEVITY CORPORATION Reports Q1 Revenue $340.1M, vs. Street Est of $319.2M

MT Newswires16:49 ET

Express News | Ingevity Reports First Quarter 2024 Financial Results

Reuters16:15 ET

Express News | Ingevity Q1 Gross Profit USD 99.7 Million

Reuters16:15 ET

Express News | Ingevity Outlook FY Sales USD 1,400-1,550 Million

Reuters16:15 ET

Express News | Ingevity Q1 Sales USD 340.1 Million Vs. Ibes Estimate USD 319 Million

Reuters16:15 ET

Express News | Ingevity Q1 EPS USD -1.54 Vs. Ibes Estimate USD 0.32

Reuters16:15 ET

Ingevity 1Q Loss $56M >NGVT

Ingevity 1Q Loss $56M >NGVT

Dow Jones16:15 ET

Ingevity Sees FY Sales $1.4B-$1.55B >NGVT

Ingevity Sees FY Sales $1.4B-$1.55B >NGVT

Dow Jones16:15 ET

Ingevity (NGVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Yahoo FinanceApr 24 10:01 ET

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist and deregister its Class A common stock.

BenzingaApr 22 13:26 ET

AU, NG and AREC Are Among Materials Movers

Seeking AlphaApr 22 13:12 ET